openPR Logo
Press release

Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online

10-07-2021 09:38 AM CET | Health & Medicine

Press release from: Pipelinepharma

The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round.

Pipelinepharma is a B2B pharmaceutical marketplace that connects pharmaceutical manufacturers with distributors around the globe. The marketplace has already facilitated pharmaceutical product licensing, supply, acquisition deals of more than €200M in value covering more than 30 markets on 5 continents.

The investment will be realized to attract top talent to the engineering, data science, pharmaceutical sales and marketing teams, further building upon Pipelinepharma’s mission - to make pharmaceutical products more affordable for every human on the planet.

“We are certain that future pharmaceutical B2B partnerships deals will take place online. The disruption of traditional dealmaking due to the pandemic only accelerated the shift to digital channels. Our database of vetted pharmaceutical products and qualified manufacturers accelerates product discovery, streamlines negotiations and significantly reduces business development costs”,- noted co-founder and CEO of Pipelinepharma Mindaugas Zagorskis.

Pipelinepharma features one the largest databases of qualified finished dosage formulation products, with more than 60 000 pharmaceuticals from 1 300 qualified manufacturers - a list which is rapidly expanding every day. Each product features rich up-to-date data, including country of origin, dossier type, GMP approvals and many more, which significantly reduce product discovery and dossier auditing time.

Deals on the platform are supervised by Pipelinepharma business development executives, who help to maximise the transaction success.

“Our business associates have a direct working relationship with manufacturers featured on the platform, perform buyer qualification and assist in finding the best buyer and seller match up until the signature of 1-page-term-sheet and agreement”, - added Mindaugas Zagorskis.

In the words of Mindaugas Zagorskis, Pipelinepharma reduces time-to-term-sheet to 30 days - a process which in traditional pharmaceutical dealmaking took months or even years to complete.

The seed round was led by Practica Capital, who were also the initial investors in the Pipelinepharma platform.

“The digital transformation of pharmaceutical commerce was long overdue. We regard this as one of the fastest growth areas in the digital healthcare landscape with Pipelinepharma well positioned to lead in this field”, - noted Mr Tomas Andriuškevičius, Partner at Practica Capital.

Iron Wolf Capital invested €450 000 in this round. In the words of Mr Žygimantas Susnys, a partner at Iron Wolf Capital, PipelinePharma has already made significant inroads in shifting pharmaceutical B2B dealmaking online.

“Pipelinepharma is introducing innovation into the €300B generic pharmaceutical market which still relies on supply contracts primarily sourced through offline events, trade fairs or pharmaceuticals brokers. With its marketplace, Pipelinepharma introduces business development simplicity into one of the key areas of global trade”, - added Žygimantas Susnys.

www.pipelinepharma.com
Vito Gerulaičio g. 1-1,
LT-08200 Vilnius
Lithuania

ABOUT PIPELINEPHARMA

Pipelinepharma is a B2B pharmaceutical marketplace that connects pharmaceutical manufacturers with distributors around the globe. For platform sellers - pharmaceutical manufacturers, it helps to find qualified buyers, sign new licensing and supply agreements and launch new markets. For buyers - pharmaceutical companies, distributors, pharmacy chains, it helps faster to build a portfolio pipeline directly connecting them with qualified manufacturers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online here

News-ID: 2420380 • Views:

More Releases from Pipelinepharma

Pipelinepharma marketplace records quadruple growth over a single year
The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming
Cooperative buying to help launch new medicines in small markets
Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma's mission to provide better access to medicines for patients all around the world. According to the CEO of Pipelinepharma Mindaugas Zagorskis, smaller pharmaceutical markets are
Pharmaceutical companies shift to near-shore medicines sourcing as supply chain …
With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. According to the data from Pipelinepharma B2B pharmaceutical marketplace, the number of requests for commercial proposals from European distributors when drug manufacturers are also based in Europe, have increased by 69% in 2021, compared to the previous year. “These Europe-to-Europe deals indicate distributor interest to shorten

All 4 Releases


More Releases for Capital

Venture Capital Investment Market Is Booming Worldwide | Accel, Benchmark Cap …
Venture Capital Investment Market: The extensive research on Venture Capital Investment Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Venture Capital Investment Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the market, such as
Venture Capital & Private Equity Firms Market is Going to Boom | TPG Capital, GG …
The latest independent research document on Venture Capital & Private Equity Firms examine investment in Market. It describes how companies deploying these technologies across various industry verticals aim to explore its potential to become a major business disrupter. The Venture Capital & Private Equity Firms study eludes very useful reviews & strategic assessment including the generic market trends, emerging technologies, industry drivers, challenges, regulatory policies that propel the market growth,
Venture Capital Investment Market 2021 Is Booming Worldwide | Accel, Benchmark C …
Venture Capital Investment Market describes an in-depth evaluation and Covid19 Outbreak study on the present and future state of the Venture Capital Investment market across the globe, including valuable facts and figures. Venture Capital Investment Market provides information regarding the emerging opportunities in the market & the market drivers, trends & upcoming technologies that will boost these growth trends. The report provides a comprehensive overview including Definitions, Scope, Application, Production
Risk Capital Investment Market Business Development Strategies 2020-2026 by Majo …
Risk Capital Investment Market - Global Analysis is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and
Global Venture Capital Investment Market, Top key players are Accel, Benchmark C …
Global Venture Capital Investment Market Report 2019 - History, Present and Future The global market size of Venture Capital Investment is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global Venture Capital Investment Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional
Venture Capital Investment Market 2019 Trending Technologies, Developments, Key …
Fintech solutions provide alternative finance firms with a platform for investors to directly come across companies and individuals looking for equity financing and debt. The technology has enabled new players to take faster decisions, engage with customers more precisely, and run operations at low cost-to-income ratios compared with traditional banks This report studies the Venture Capital Investment market status and outlook of Global and major regions, from angles of players,